{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:12:57Z","timestamp":1793261577925,"version":"4.5.0"},"reference-count":15,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T00:00:00Z","timestamp":1237766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>The objective of this study was to determine whether levetiracetam (LEV) is an effective drug for treatment of trigeminal neuralgia (TN).<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>Ten patients with TN were enrolled in a 10\u2010week, prospective, open\u2010label pilot study. The primary outcome measure was the visual analogue scale on daily pain diary and side effects. Serum levels of LEV were measured to assess correlation between drug levels and pain control.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>There was a significant tendency towards improvement in pain severity compared with baseline in four patients with higher doses of 4\u2003000\u2003mg\/day. The four treatment responders had less pain compared with baseline (50\u201390% improvement) and three subjects continued the drug after study completion. All patients rated themselves on the global evaluation scale as much improved (<jats:italic>n<\/jats:italic>\u2003=\u20032), minimally improved (<jats:italic>n<\/jats:italic>\u2003=\u20033), no change (<jats:italic>n<\/jats:italic>\u2003=\u20031), minimally worse (<jats:italic>n<\/jats:italic>\u2003=\u20032), much worse (<jats:italic>n<\/jats:italic>\u2003=\u20031) and very much worse (<jats:italic>n<\/jats:italic>\u2003=\u20031). LEV was very well tolerated and there was no difference in side effects between the low and high doses of LEV evaluations.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold>Given its established safety profile, a randomized, placebo\u2010controlled, double\u2010blind trial of LEV using enhancement enrolment design is needed to confirm these open\u2010labelled findings using a wide variety of outcome measures.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2009.02585.x","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T12:26:05Z","timestamp":1237811165000},"page":"740-744","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra<sup>\u00ae<\/sup>) in treatment of patients with trigeminal neuralgia"],"prefix":"10.1111","volume":"16","author":[{"given":"T. P.","family":"Jorns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,28]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7012.1047"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/02688690701219175"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.24501.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.17.1375.34432"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1358\/mf.2003.25.2.723686"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(99)00052-2"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.02.003"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.111006369.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(24)37251-9","article-title":"Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy","volume":"284","author":"Loscher W","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"e_1_2_7_11_2","first-page":"306","article-title":"Levetiracetam for the treatment of trigeminal neuralgia","volume":"45","author":"Edwards KR","year":"2004","journal-title":"Epilepsia"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000079463.16377.07"},{"issue":"1","key":"e_1_2_7_13_2","first-page":"9","article-title":"The International Classification of Headache Disorders: Second edition","volume":"24","author":"Anonymous.","year":"2004","journal-title":"Cephalalgia"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(86)90157-0"},{"key":"e_1_2_7_15_2","first-page":"285","article-title":"Pain descriptors characteristic of persistent facial pain","volume":"11","author":"Turp JC","year":"1997","journal-title":"J Orofac Pain"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.65.12_suppl_4.S32"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2009.02585.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2009.02585.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T16:42:20Z","timestamp":1739032940000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2009.02585.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1468-1331.2009.02585.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02585.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]},"assertion":[{"value":"2009-04-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}